Expression of Serum Soluble E-Cadherin before and after Operation and Postoperative Recurrence in Hepatocellular Carcinoma Patients

YUAN Lin; XU Youxian; SHEN Shiqiang; LU Xin

doi:10.3971/j.issn.1000-8578.2014.02.014

Cancer Research on Prevention and Treatment > 2014 > 41(02): 153-156. > DOI: 10.3971/j.issn.1000-8578.2014.02.014

YUAN Lin, XU Youxian, SHEN Shiqiang, LU Xin. Expression of Serum Soluble E-Cadherin before and after Operation and Postoperative Recurrence in Hepatocellular Carcinoma Patients[J]. Cancer Research on Prevention and Treatment, 2014, 41(02): 153-156. DOI: 10.3971/j.issn.1000-8578.2014.02.014

Citation:

PDF (887 KB)

Expression of Serum Soluble E-Cadherin before and after Operation and Postoperative Recurrence in Hepatocellular Carcinoma Patients

1. Department of General Surgery,The People's Hospital of Liuzhou, Liuzhou545006, China;2. Department of General Surgery, Renmin Hospital of Wuhan University

More Information

Received Date: December 09, 2012
Revised Date: May 02, 2013

Graphical Abstract

Abstract

Abstract

Objective To detect the expression levels of serum soluble E-cadherin(sEC) before and after operation in hepatocellular carcinoma(HCC) patients and to monitor postoperative recurrence of HCC. Methods The levels of sEC in 105 HCC patients were tested by enzyme linked immunosorbent assay(ELISA) before and after operation as well as in 70 healthy controls. Their correlations with clinical and pathological factors were also analyzed. Retrospectively the level of plasma sEC of 47 patients who had been suffered from the HCC operation and relapse were also analyzed. Results The levels of sEC in hepatocellular carcinoma(HCC) patients before operation were significantly higher than those in controls. Which declined signifi cantly one week after operation.The sEC levels before operation showed signifi cant correlation with TNM stages(P<0.01), Edmondson grade, the cancerous thrombi within the portal vein and the capsule of carcinoma (P<0.05), but not with age of patients or tumor size(P>0.05). Conclusion The levels of sEC in HCC patients before operation is closely related with clinical stages, which may be a predictive factor for prognosis and recurrence of HCC.
- Serum,
- Soluble E-cadherin,
- Hepatocellular carcinoma,
- Operation,
- Recurrence

FullText(HTML)

References (10)

References

[1]	de Lope CR, Tremosini S, Forner A, et al. Management of HCC[J]. J Hepatology, 2012, 56 Suppl 1: S75-87.
[2]	Zuo T, Huang J, Xie SP, et al. Characteristics and significance of VEGF-C and E-cadherin proteins in non-small cell lung cancer[J]. Zhong Liu Fang Zhi Yan Jiu,2013,40(1):72-5.[左涛,黄杰,谢颂平, 等. VEGF-C和E-cadherin在非小细胞肺癌中的表达及意义[J]. 肿瘤防治研究,2013,40(1):72-5.]
[3]	Yuan L, Shen SQ, Xiong CL, et al. Expression and clinical significance of E-Cadherin in hepatocellular carcinoma[J]. Lin Chuang Wai Ke Za Zhi, 2004,12(7):407-8.[袁林, 沈世强, 熊成龙, 等. E-钙黏蛋白在肝细胞癌中的表达及临床意义[J].临床外科杂志,2004,12(7):407-8.]
[4]	Jiang J, Wu C, Shen Y, et al. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma[J].Anticancer Res,2011,31(2):687-91.
[5]	Chen H, Li JS, Jia WD,et al. The prognostic significance of preoperative serum levels of extracellular matrix protein 1 in patients with hepatocellular carcinoma[J].Zhonghua Pu Tong Wai Ke Za Zhi,2012,27(7):582-5.[陈浩,李建生,荚卫东,等. 肝细胞癌患者血清细胞外基质蛋白1表达水平与术后复发及预后的关系 [J] 中华普通外科杂志,2012,27(7):582-5.]
[6]	Li CY, Shen AR, Zhang ZS, et al. Expression and its clinical significance of serum soluble E-cadherin before and after operation in ovarian cancer[J].Henan Wai Ke Za Zhi,2012,18(5):6-7.[李灿宇,申爱荣,张自森,等. 检测血清可溶性 E-钙粘连蛋白在卵巢癌手术前后的表达及其意义[J]．河南外科学杂志,2012,18(5):6-7.]
[7]	Zhang ZS, Wu M, Ba N, et al.Pre-and post-chemotherapy expression of serum soluble E-cadherin and its clinical signifi cance in gastric cancer patients[J].Lin Chuang Zhong Liu Xue Za Zhi,2011,16(9):820-2.[张自森,吴敏,巴楠,等. 晚期胃癌血清可溶性E-钙粘连蛋白的表达及其意义[J]. 临床肿瘤学杂志,2011,16(9):820-2.]
[8]	Novák J,Fabian P. Comments on the TNM classification of malignant tumours-7th edition[J].Klin Onkol,2011,24(2):149-50.
[9]	Liao WJ, Mei MH, Qin LL. Signifieance of AFP and ICAM-1 Monitoring in Recurrence Primary Liver Caner afte rRadical Resection[J]. Xian Dai Jian Yan Yi Xue Za Zhi,2007,22(4):83-4.[廖维甲,梅铭惠,覃理灵. 联合检测AFP与ICAM-1在原发性肝癌根治性切除术后复发的意义[J]. 现代检验医学杂志, 20 07,22(4):83-4.]
[10]	Shim HS, Yoon BS, Cho NH, et al. Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma[J]. Hum Pathol,2009,40(5):693-8．

[1]	XIAO Jincheng, GUO Leiming, KANG Xinxin, BAI Qiwen, ZHANG Junling, LI Jing. Comparison of Efficiency and Safety Between Radiofrequency Ablation and Stereotactic Body Radiotherapy on Primary Small Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 831-835. DOI: 10.3971/j.issn.1000-8578.2017.17.0613
[2]	LU Sicong, LU Haiming, LIU Lei, JIANG Shuiming, ZHANG Qishun. Emergency Transcatheter Arterial Embolization Combined with Two-stage Liver Resection for Spontaneous Ruptured Hepatocellular Carcinoma: A Systematic Review[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 997-1000. DOI: 10.3971/j.issn.1000-8578.2015.10.010
[3]	LU Jingning, YANG Hong, PENG Minhao, XIAO Kaiyin, PENG Tao, PENG Jinbo. Percutaneous Ultrasound-guided Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in Hepatic Dome[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 493-497. DOI: 10.3971/j.issn.1000-8578.2015.05.016
[4]	Shen Xinying, Zhang Yanfang, Kong Jian, Dou Yongchong, Li Yong, Cai Jinzhong, He Fan, Chen Xudong. Therapeutic Value of Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma with Arterioportal Shunts[J]. Cancer Research on Prevention and Treatment, 2012, 39(09): 1120-1124. DOI: 10.3971/j.issn.1000-8578.2012.09.016
[5]	PENG Qi-rong, XIAO Bi, ZHANG Jian, CHENG Tao, CHEN Guo-qiang. Percutaneous Microwave Coagultion Therapy Influence on Hepatofibrosis of Primary Hepatocellular Carcinoma Serum[J]. Cancer Research on Prevention and Treatment, 2011, 38(03): 322-323. DOI: 10.3971/j.issn.1000-8578.2011.03.022
[6]	HUANG Jin-qiu, PENG Min-hao, ZOU Quan-qing, YANG Ding-hua, CHEN Bin, XIAO Kai-yin. Cox Model Analysis of Prognostic Factors after Radical Hepatectomy for Primary Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(02): 137-139. DOI: 10.3971/j.issn.1000-8578.2009.02.015
[8]	MA Guoan. RFA Combined with TACE for Primary Hepatic Carcinoma[J]. Cancer Research on Prevention and Treatment, 2006, 33(12): 905-907. DOI: 10.3971/j.issn.1000-8578.3352
[9]	SONG Bin, WANG Wei-xing, ZHANG Wen, et al. Effect of the different combined therapy methods of transcatheter arterial chemoembolization (TACE) and percutaneous radio-frequency ablation(RF) on the elder patients with unresectable hepatocellular carcinoma(HCC)[J]. Cancer Research on Prevention and Treatment, 2003, 30(06): 496-497. DOI: 10.3971/j.issn.1000-8578.2920
[10]	Jiang Xiao-Qing, Yin Guang-fu, Su Ka-qing, Wang Hao. Study on apoptosis of hepatocellular carcinoma cells after intrahepatic arterial angiotensin Ⅱ infusion induced hypertension and chemoembolization (IHCE )[J]. Cancer Research on Prevention and Treatment, 1996, 23(6): 350-351.

Cited By

Get Citation

PDF

XML

Article views (1306) PDF downloads (591)

Turn off MathJax

Article Contents

Abstract

References

Expression of Serum Soluble E-Cadherin before and after Operation and Postoperative Recurrence in Hepatocellular Carcinoma Patients

Abstract

References

Related Articles

Catalog

Download Center

Links

Contact Us

Expression of Serum Soluble E-Cadherin before and after Operation and Postoperative Recurrence in Hepatocellular Carcinoma Patients

Abstract

References

Related Articles

Catalog

Download Center

Links

Contact Us

Export File

Citation

Format

Content